Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Oral Care in connection with the acquisition of Dutch dental care provider De Tandartsengroep (DTG)
Mandate

Vinge advises Oral Care in connection with the acquisition of Dutch dental care provider De Tandartsengroep (DTG)

February 19, 2025 Banking and Finance Employment and Benefits M&A Intellectual Property Commercial Agreements

DTG operates 31 clinics and 8 dental laboratories in the Netherlands. Oral Care is a portfolio company of Axcel VI and operates a network of dental clinics in Sweden, Norway and the Netherlands. To support this expansion, Axcel VII is joining Axcel VI as a shareholder in Oral Care.

The transaction is subject to customary approval by the Dutch Health Care Authority and the Dutch Authority for Consumers and Markets (ACM).

Vinge's team consisted of Christina Kokko, Manon de Cooman, Gustav Wahlberg, Helena Liljenberg, Josef Groow (M&A), Alice Göransson (Employment Law), Avid Axelryd (Intellectual Property), Calle Tengwall Pagels, August Ahlin, Sara Jansson (Banking and Finance), Carla Håkansson, Katja Hägglund (Commercial Agreements), Frida Lansfjord, Jacob Guve, Alma Rotsman, Augus Olding (Assistants).

Read the client's press release here.

Related

Vinge has advised Gamma Waves on Sportway’s EUR 20 million financing round

 Vinge has acted as legal adviser to Gamma Waves in connection with Sportway’s EUR 20 million financing round. The round was led by Gamma Waves, together with continued participation from existing shareholders, and values Sportway at approximately EUR 92 million (around SEK 1 billion) post-money.
June 24, 2026

Vinge advises Spotlight Group in connection with offer from Kriptown

 Vinge is advising Spotlight Group AB (publ) in connection with Kriptown SAS having made a public cash takeover offer to the shareholders of Spotlight Group
June 17, 2026

Vinge has advised EQT IX in connection with its exit of Beijer Ref AB (publ)

 Vinge has advised EQT IX (”EQT”) in connection with the sale of all of its remaining shares of series B in Beijer Ref AB (publ) through an accelerated bookbuilding process carried out on 15 June 2026.
June 16, 2026